Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.900
+0.020 (1.06%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.67 million as of February 21, 2025. Its market cap has increased by 273.42% in one year.
Market Cap
3.67M
Enterprise Value
-1.10M
1-Year Change
273.42%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.67M, a decrease of -91.08%. That is a compound annual growth rate of -54.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.67M | -6.40% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |